Skip to main content
. 2021 Mar 26;126(6):735–738. doi: 10.1016/j.anai.2021.03.012

Table 1.

Characteristics and Skin Test Results of Patients With Reaction to First COVID-19 Vaccine Dose and Previous PEG/Polysorbate Allergya

Patient Age/sex Previous allergic disease Culprit agents Symptoms Anaphylaxisb Time to onset Treatment ED Time to resolution Skin test performed Time from reaction to the skin test Skin test result Time between vaccine doses Vaccine outcomec
1 24F None Pfizer-BioNTech vaccine Urticaria No 3 h Antihistamines No 4 d PEG 12 d Negative 23 d No reaction
2 54F Drug allergy Pfizer-BioNTech vaccine Tachycardia, rhinorrhea No 10 min None No 10 min PEG, MP acetate 7 d Negative 18 d No reaction
3 36F None Pfizer-BioNTech vaccine Facial flushing No 5 min Antihistamines No 1 h PEG, MP acetate, TC acetonide 20 d Negative 21 d No reaction
4 52M Venom anaphylaxis Pfizer-BioNTech vaccine Oral pruritus, throat fullness No Immediate None No 5 min PEG 10 d Negative 21 d No reaction
5 45F Food allergy Pfizer-BioNTech vaccine Urticaria, throat tightness No 8 h None No Unknown PEG 20 d Negative 29 d No reaction
6 33F Asthma, venom anaphylaxis Pfizer-BioNTech vaccine Urticaria, tachycardia No 15 min Antihistamines No 12-24 h PEG 20 d Negative 23 d No reaction
7 20M Vaccine allergy (flu) Moderna vaccine Angioedema No 3 h Steroids, antihistamines Yes 24 h Expandedd 20 d Negative N/A Not given
8 22F Allergic rhinitis Moderna vaccine Angioedema, wheezing, throat pruritus Level 1 20 min Antihistamines, steroids Yes 6 h Expandedd 21 d Negative 51 d Minor lip/tongue tingling
9 69M Drug allergy Moviprep (PEG) Rash, flushing No During prep Antihistamines No 1 h PEG 2 y Negative N/A No reaction (Pfizer)
10 73F Asthma, drug allergy Moviprep (PEG) Headache, nausea No Unknown Unknown No Unknown PEG 5 y Negative N/A No reaction (Moderna)
11 46F Vaccine allergy (flu) Methylprednisolone acetate (PEG) Urticaria, dizzy, flushing No 15 min Epinephrine, steroids, antihistamines No 12 h Expandedd 3 mo Positive (PEG and MP acetate)e N/A Not given
12 74M Drug allergy Triamcinolone acetonide (polysorbate 80) Urticaria, wheezing Level 1 1 h Steroids, antihistamines Yes Unknown PEG, MP acetate, TC acetonide 3 y Negative N/A No reaction (Pfizer)
13 55F Anaphylaxis Influenza vaccinesf (polysorbate 20/80) Flushing, wheezing, cough, throat tightness Level 1 20 min Epinephrine, steroids, antihistamines Yes Unknown PEG, Polysorbate 20 7 y Negative N/A No reaction (Pfizer)
14 67F Food allergy, anaphylaxis MiraLAX (PEG) Oral urticaria No 2 h Unknown No Unknown Expandedd Unknown Negative N/A No reaction (Moderna)
15 60M Vaccine allergy (Shingrix) Shingrix (polysorbate 80) Flushing, urticaria No 2 h Antihistamines, steroids Yes 2 d Expandedd 3 mo Negative N/A No reaction (Moderna)

Abbreviations: COVID-19, coronavirus disease 2019; ED, emergency department; F, female; M, male; MP, methylprednisolone; PEG, polyethylene glycol; TC, triamcinolone.

a

Patients 1 to 8: reaction to first COVID vaccine dose; patients 9 to 15: no previous vaccine dose, reported previous PEG or polysorbate allergy.

b

Determined by using the Brighton criteria.9

c

Refers to second vaccine dose in patients 1 to 8 or first vaccine dose in patients 9 to 15. All doses were given with a 30-minute observation period.

d

Expanded skin testing included PEG, methylprednisolone acetate, methylprednisolone sodium, triamcinolone acetonide, and polysorbate 20.

e

PEG 1:1 skin prick: 5 × 5 wheal, 10 × 10 flare; methylprednisolone acetate 0.1 mg/mL intradermal: 6 × 6 wheal, 8 × 8 flare (all measurements in mm).

f

H1N1 vaccines FluBlok and Fluxrix.